Mental Status and Quality of Life of Post-COVID-19 Patients
Assessment of Mental Status and Quality of Life of Patients Admitted to the Rehabilitation Unit After COVID-19 Hospitalization
1 other identifier
observational
147
1 country
1
Brief Summary
The current SARS-CoV-2 virus pandemic has already affected the lives of every person on earth. Most of the information given in the media on a daily basis focuses on the pandemic aspects. Fear of getting sick arises in the population, and once infection occurs, numerous concerns arise over the course of the disease. For some patients, hospitalization and subsequent rehabilitation is needed due to complications from the disease. Besides the aspect of treating patients physically from the disease, the psychological aspects that often accompany patients during and after the disease are not addressed. Depressive and anxiety symptoms can follow patients for many years and can affect their quality of life. Thus, the purpose of this project is to assess the mental status of patients prior to the inpatient rehabilitation program
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 7, 2021
CompletedFirst Submitted
Initial submission to the registry
July 1, 2021
CompletedFirst Posted
Study publicly available on registry
July 2, 2021
CompletedAugust 9, 2021
August 1, 2021
3 months
July 1, 2021
August 1, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Hospital Anxiety and Depression Scale (HADS)
The Hospital Anxiety and Depression Scale (HADS) is a fourteen-item scale scoring from 0 to 3 for each item. The first seven items relate to anxiety (HADS-A), and the remaining seven items relate to depression (HADS-D). The global scoring ranges from 0 to 42 with a cut-off point of 8/21 for anxiety and 8/21 for depression. The higher the score, the greater anxiety or depression symptoms. HADS will be performed at the beginning and after four weeks of treatment.
15 minutes
Perceived stress scale (PSS-10)
The Perceived Stress Scale (PSS) is the most widely used psychological instrument for measuring the perception of stress. It is a measure of the degree to which situations in one's life are appraised as stressful. Items were designed to tap how unpredictable, uncontrollable, and overloaded respondents find their lives.
15 minutes
WHOQOL-BREF
The WHOQOL-BREF is a shorter version of the WHOQOL-100. Both were developed by the World Health Organisation (WHO) and published in 1995. It was developed over several years and from 15 centres around the world. The questions stem from multiple statements about quality of life, health and well-being from people with and without disease, and health professionals. It has been tested for reliability and validity. The WHOQOL-BREF is a self-administered questionnaire comprising 26 questions on the individual's perceptions of their health and well-being over the previous two weeks. Responses to questions are on a 1-5 Likert scale where 1 represents "disagree" or "not at all" and 5 represents "completely agree" or "extremely".
10 minutes
Secondary Outcomes (2)
Six-Minute Walk Test (6MWT)
10 minutes
Spirometry Test
20 minutes
Study Arms (1)
COVID-19 survivors
Interventions
Patients qualified for rehabilitation will be assessed for stress levels as well as symptoms of anxiety and depression and quality of life before rehabilitation began
Eligibility Criteria
COVID-19 caused by SARS-CoV-2 has led to a global public health crisis. Clinical symptoms of patients with COVID-19 infection include fever, sore throat, coughing, fatigue, or gastrointestinal infections, which can appear in a smaller population of patients. In more severe cases, respiratory failure symptoms, as well as heart and kidney damage, may occur. This can happen especially in the elderly and in people with other concomitant chronic diseases. Furthermore, the COVID-19 pandemic gives rise to new psychosocial and emotional stressors for recovering patients, including social isolation, physical distancing, loss of employment and uncertainties about the future. Remarkably, many mental problems will continue long after the pandemic is over, some of which will only begin to emerge in the near future.
You may qualify if:
- Previously hospitalized for SARS-CoV-2 infection;
- Pulmonary rehabilitation conducted in ward settings
You may not qualify if:
- Inability to self-complete the research questionnaires;
- Presence of the following issues at the time of the examination or in the medical data: disturbances of consciousness, psychotic symptoms or other serious psychiatric disorders
- Initiation of psychiatric treatment during the research project;
- Patient's refusal at any stage of the research project.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Ministry of the Interior and Administration Hospital
Głuchołazy, 48-340, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Joanna Szczepańska-Gieracha, Prof
University School of Physical Education, Department of Physiotherapy, Wroclaw, Poland
- STUDY CHAIR
Sebastian Rutkowski, PhD
The Opole University of Technology, Opole, Poland
- PRINCIPAL INVESTIGATOR
Patryk Szary, MSc
University School of Physical Education, Department of Physiotherapy, Wroclaw, Poland
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 1, 2021
First Posted
July 2, 2021
Study Start
March 1, 2021
Primary Completion
May 28, 2021
Study Completion
June 7, 2021
Last Updated
August 9, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share